{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T21:39:47Z","timestamp":1769981987573,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.eplepsyres.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:24:06Z","timestamp":1429316646000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Intravenous levetiracetam treatment in status epilepticus: A prospective study"],"prefix":"10.1016","volume":"114","author":[{"given":"Murat Mert","family":"Atmaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Kocasoy","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerses","family":"Bebek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"Gurses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2010.10.009","article-title":"Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study","volume":"20","author":"Aiguabella","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","article-title":"Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam","volume":"52","author":"Alvarez","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00415-009-5166-7","article-title":"Intravenous levetiracetam as treatment for status epilepticus","volume":"256","author":"Berning","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000166610","article-title":"Intravenous levetiracetam for epileptic seizure emergencies in older people","volume":"55","author":"Beyenburg","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/08830738050200060201","article-title":"Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin","volume":"20","author":"Brevoord","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1468-1331.2008.02404.x","article-title":"Clinical features of convulsive status epilepticus: a study of 220 cases in western China","volume":"16","author":"Chen","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.58.1.139","article-title":"Predictors of functional disability and mortality after status epilepticus","volume":"58","author":"Claassen","year":"2002","journal-title":"Neurology"},{"issue":"Pt 2","key":"10.1016\/j.eplepsyres.2015.04.003_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/119.2.393","article-title":"Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK","volume":"119","author":"Cockerell","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/ern.10.3","article-title":"Levetiracetam: a comprehensive review","volume":"10","author":"Crepeau","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.seizure.2009.06.009","article-title":"Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model","volume":"18","author":"Dudra-Jastrzebska","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.yebeh.2009.05.020","article-title":"Two years of experience in the treatment of status epilepticus with intravenous levetiracetam","volume":"15","author":"Eue","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/11311100-000000000-00000","article-title":"Experience with intravenous levetiracetam in status epilepticus: a retrospective case series","volume":"23","author":"Gamez-Leyva","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0065","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.59.9_suppl_5.S3","article-title":"Seizure-induced neuronal injury: animal data","volume":"59","author":"Holmes","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wnp.0000220837.99490.66","article-title":"The EEG of status epilepticus","volume":"23","author":"Kaplan","year":"2006","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.2007.130260","article-title":"Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus","volume":"79","author":"Knake","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0080","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2008.145458","article-title":"Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus","volume":"80","author":"Moddel","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.eplepsyres.2015.04.003_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/brain\/108.1.193","article-title":"The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy","volume":"108","author":"Obeso","year":"1985","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000087385","article-title":"Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes","volume":"54","author":"Rossetti","year":"2005","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yebeh.2008.01.004","article-title":"Intravenous levetiracetam: treatment experience with the first 50 critically ill patients","volume":"12","author":"Ruegg","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eplepsyres.2006.10.011","article-title":"Levetiracetam as a treatment option in non-convulsive status epilepticus","volume":"73","author":"Rupprecht","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0140","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archneur.1977.00500170020003","article-title":"Epilepsia partialis continua. A review of 32 cases","volume":"34","author":"Thomas","year":"1977","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1756285608100460","article-title":"New treatment options in status epilepticus: a critical review on intravenous levetiracetam","volume":"2","author":"Trinka","year":"2009","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2006.12.005","article-title":"Childhood status epilepticus and excitotoxic neuronal injury","volume":"36","author":"Tsuchida","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1528-1167.2008.01889.x","article-title":"Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus","volume":"50","author":"Uges","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2015.04.003_bib0170","series-title":"Epilepsy: A Comprehensive Textbook","first-page":"705","article-title":"Simple partial status epilepticus and epilepsia partialis continua of Kozhevnikov","author":"Wieser","year":"2008"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:33:15Z","timestamp":1760275995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121115000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":34,"alternative-id":["S0920121115000765"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.04.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous levetiracetam treatment in status epilepticus: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}